Correlation of human papillomavirus 16 and 18 with cervical neoplasia in histological typing and clinical stage in taiwan: An in-situ polymerase chain reaction approach

被引:10
作者
Shyu, JS
Chen, CJ
Chiu, CC
Huang, SC
Harn, HJ
机构
[1] Tri Serv Gen Hosp, Dept Pathol, Taipei 114, Taiwan
[2] Armed Force Taoyuan Hosp, Dept Pathol, Taoyuan, Taiwan
[3] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan
[4] Armed Force Taoyuan Hosp, Dept Surg, Taoyuan, Taiwan
[5] Tri Serv Gen Hosp, Dept Emergency Med, Taipei, Taiwan
关键词
in situ polymerase chain reaction; human papillomavirus; human cervical cancer;
D O I
10.1002/jso.1128
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background and Objectives: ln situ polymerase chain reaction (ISPCR) promises to considerably enhance our ability to detect a few copies of target nucleic acid sequences in fixed tissues and cells. The aim of this study was to investigate cervical carcinoma to determine the human papillomavirus (HPV) types on paraffin-embedded tissue sections by ISPCR and standard in situ hybridization. The results will correlate the morphological characteristics of lesions with viral typing results. Methods: This study examined prevalence of HPV 16 and 18 DNA in biopsies from 85 cervical cancer patients by ISPCR, employing HPV 16, 18 consensus primers. There are 45 patients with squamous cell carcinomas, 13 with adenocarcinoma, 2 with adenosquamous carcinomas, 3 with small cell carcinomas, and 22 carcinoma in situ. The relation between the types of HPV detected, tumor type, and clinical stage were analyzed. Results: Fifty-two of 85 biopsies were HPV 16- or 18-positive, HPV 16 being the most prevalent type. Squamous cell carcinoma had a high prevalence of HPV 16 and adenocarcinoma had a high prevalence of HPV 18. HPV 18 was the predominant type among high clinical stage (III-IV) cases while HPV 16 and mixed HPV 16 with HPV18 were significantly correlated with low clinical stage (0-I-II). Conclusion: Our results indicate that certain malignant cervical tumor phenotypes and stages correlate with specific HPV type, and that ISPCR is a sensitive and fast method to detect HPV in these patients. J. Surg. Oncol. 2001;78:101-109. (C) 2001 Wiley-Liss, Inc.
引用
收藏
页码:101 / 109
页数:9
相关论文
共 38 条
[1]  
ABELER VM, 1994, CANCER, V73, P672, DOI 10.1002/1097-0142(19940201)73:3<672::AID-CNCR2820730328>3.0.CO
[2]  
2-R
[3]   DETECTION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 PROVIRUS IN MONONUCLEAR-CELLS BY INSITU POLYMERASE CHAIN-REACTION [J].
BAGASRA, O ;
HAUPTMAN, SP ;
LISCHNER, HW ;
SACHS, M ;
POMERANTZ, RJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 326 (21) :1385-1391
[4]   THE REGION OF THE HPV E7 ONCOPROTEIN HOMOLOGOUS TO ADENOVIRUS E1A AND SV40 LARGE T-ANTIGEN CONTAINS SEPARATE DOMAINS FOR RB BINDING AND CASEIN KINASE-II PHOSPHORYLATION [J].
BARBOSA, MS ;
EDMONDS, C ;
FISHER, C ;
SCHILLER, JT ;
LOWY, DR ;
VOUSDEN, KH .
EMBO JOURNAL, 1990, 9 (01) :153-160
[5]   PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[6]  
CHEN SL, 1993, CANCER-AM CANCER SOC, V72, P1939, DOI 10.1002/1097-0142(19930915)72:6<1939::AID-CNCR2820720624>3.0.CO
[7]  
2-2
[8]  
CHIU K, 1992, J HISTOCHEM CYTOCHEM, V4, P333
[9]   IMMUNOHISTOCHEMICAL STUDIES ON UTERINE-TUMORS .1. INVASIVE SQUAMOUS-CELL CARCINOMAS OF THE CERVIX AND THEIR PRECURSORS [J].
DALLENBACHHELLWEG, G ;
LANG, G .
PATHOLOGY RESEARCH AND PRACTICE, 1991, 187 (01) :36-43
[10]   HETEROGENEITY OF THE HUMAN PAPILLOMAVIRUS GROUP [J].
DEVILLIERS, EM .
JOURNAL OF VIROLOGY, 1989, 63 (11) :4898-4903